Martinsried, Germany

Michael Thormann

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovations of Michael Thormann

Introduction

Michael Thormann is a prominent inventor based in Martinsried, Germany, known for his contributions in the field of biochemistry and pharmacology. With a prolific career, he holds an impressive portfolio of 16 patents, focusing primarily on the development of novel kinase inhibitors aimed at treating a wide array of diseases.

Latest Patents

Thormann's latest patents introduce innovative compounds capable of inhibiting specific kinases, including Spleen Tyrosine Kinase (SYK), Leucine-rich Repeat Kinase 2 (LRRK2), and Myosin Light Chain Kinase (MYLK). These compounds have been designed for therapeutic applications in various medical conditions, such as autoimmune diseases, inflammatory diseases, bone diseases, metabolic disorders, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, Alzheimer's disease, Parkinson's disease, skin disorders, eye diseases, infectious diseases, and hormone-related diseases. By targeting these critical kinases, Thormann's inventions potentially provide new avenues for effective treatments.

Career Highlights

Throughout his career, Michael Thormann has made significant strides in the biotech industry. He has contributed substantially while working for companies like Probiodrug AG and Origenis GmbH. His work has not only advanced scientific understanding in his field but has also led to practical applications in drug development.

Collaborations

In his professional journey, Thormann has collaborated with several notable experts and colleagues. Among these are Andreas Treml and Michael Almstetter, both of whom have played vital roles in various projects alongside him. These collaborations have fostered a dynamic exchange of ideas, propelling innovative thought processes and outcomes.

Conclusion

Michael Thormann exemplifies the spirit of innovation within the scientific community. His contributions to kinase inhibitor development have opened new horizons for treating complex diseases that affect millions worldwide. As he continues to expand his research, the impact of his inventions will likely resonate through the healthcare sector for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…